Xtx Topco LTD Arrowhead Pharmaceuticals, Inc. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$26.2 - $36.08 $340,154 - $468,426	12,983 Added 193.08%	19,707 $529,000
Q2 2023 Aug 14, 2023	BUY	$25.16 - $41.38 $169,175 - $278,239	6,724 New	6,724 $239,000
Q2 2021 Aug 12, 2021	SELL	$62.15 - $90.32 $373,707 - $543,094	-6,013 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$61.35 - $90.47 $368,897 - $543,996	6,013 New	6,013 $399,000

304

96.2M

388K

420K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.11B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.